Location: New York, NY
CIK: 0001263508 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 14, 2020
Total Value: $18.81B (99.7% shares, 0.3% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Seattle Genetics, Inc. | 50,057,277 | $5.72B | 30.4% | $37.84 | — | COM | 812578102 |
| INCY | Incyte Corporation | 31,976,873 | $2.792B | 14.8% | $73.07 | +16.9% | COM | 45337C102 |
| ONC | BeiGene, Ltd. | 11,777,285 | $1.952B | 10.4% | $117.58 | — | SPONSORED ADR | 07725L102 |
| ACAD | ACADIA Pharmaceuticals Inc. | 40,854,586 | $1.748B | 9.3% | $18.28 | +138.0% | COM | 004225108 |
| — | Alexion Pharmaceuticals, Inc. | 8,258,068 | $893M | 4.7% | $166.88 | — | COM | 015351109 |
| KOD | Kodiak Sciences Inc. | 11,047,289 | $795M | 4.2% | $13.59 | +167.7% | COM | 50015M109 |
| — | Amarin Corporation plc | 34,496,685 | $740M | 3.9% | $8.93 | — | SPONSORED ADR | 023111206 |
| BMRN | BioMarin Pharmaceutical Inc. | 7,589,294 | $642M | 3.4% | $81.02 | -6.8% | COM | 09061G101 |
| ASND | Ascendis Pharma A/S | 3,390,270 | $472M | 2.5% | $44.21 | — | SPONSORED ADR | 04351P101 |
| EXAS | Exact Sciences Corporation | 2,585,791 | $239M | 1.3% | $87.91 | 0.0% | COM | 30063P105 |
| — | Mirati Therapeutics, Inc. | 1,307,220 | $168M | 0.9% | $18.61 | — | COM | 60468T105 |
| ARGX | argenx SE | 1,019,557 | $164M | 0.9% | $59.75 | — | SPONSORED ADR | 04016X101 |
| — | DBV Technologies S.A. | 14,614,264 | $156M | 0.8% | $19.06 | — | SPONSORED ADR | 23306J101 |
| — | Invitae Corporation | 9,097,165 | $147M | 0.8% | $17.07 | — | COM | 46185L103 |
| HRTX | Heron Therapeutics, Inc. | 6,018,104 | $141M | 0.8% | $17.78 | +24.5% | COM | 427746102 |
| NBIX | Neurocrine Biosciences, Inc. | 1,254,243 | $135M | 0.7% | $62.87 | +66.5% | COM | 64125C109 |
| — | MyoKardia, Inc. | 1,774,234 | $129M | 0.7% | $52.95 | — | COM | 62857M105 |
| — | IGM Biosciences, Inc. | 3,144,000 | $120M | 0.6% | $17.75 | — | COM | 449585108 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 1,169,278 | $107M | 0.6% | $110.87 | -12.5% | COM | 558868105 |
| — | Ra Pharmaceuticals, Inc. | 2,093,839 | $98.26M | 0.5% | $24.19 | — | COM | 74933V108 |
| — | Principia Biopharma Inc. | 1,787,957 | $97.94M | 0.5% | $31.13 | — | COM | 74257L108 |
| AXSM | Axsome Therapeutics, Inc. | 829,757 | $85.76M | 0.5% | $11.44 | +253.1% | COM | 05464T104 |
| — | Zymeworks Inc. | 1,708,472 | $77.67M | 0.4% | $14.76 | — | COM | 98985W102 |
| — | Tricida, Inc. | 1,969,905 | $74.34M | 0.4% | $31.61 | — | COM | 89610F101 |
| RYTM | Rhythm Pharmaceuticals, Inc. | 2,708,200 | $62.18M | 0.3% | $26.63 | -16.6% | COM | 76243J105 |
| INSM | Insmed Incorporated | 2,445,265 | $58.39M | 0.3% | $21.82 | -6.8% | COM PAR $.01 | 457669307 |
| KRYS | Krystal Biotech, Inc. | 1,034,674 | $57.3M | 0.3% | $22.57 | +117.3% | COM | 501147102 |
| — | Atreca, Inc. | 3,532,760 | $54.65M | 0.3% | $18.84 | — | CL A Common | 04965G109 |
| — | Audentes Therapeutics, Inc. | 804,720 | $48.15M | 0.3% | $31.63 | — | COM | 05070R104 |
| — | Neurocrine Biosciences, Inc. | 30,770,000 | $47.12M | 0.3% | $1.24 | — | NOTE 2.25% 5/15/2024 | 64125CAD1 |
| CERS | Cerus Corporation | 10,749,937 | $45.37M | 0.2% | $4.67 | -7.8% | COM | 157085101 |
| — | Neoleukin Therapeutics, Inc. | 3,397,740 | $41.86M | 0.2% | $2.85 | — | COM | 64049K104 |
| — | GW Pharmaceuticals plc | 370,845 | $38.78M | 0.2% | $132.99 | — | ADS | 36197T103 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 10,946,166 | $37.76M | 0.2% | $6.96 | -63.9% | COM | 09058V103 |
| QURE | uniQure N.V. | 517,700 | $37.1M | 0.2% | $18.33 | +199.5% | SHS | N90064101 |
| AUPH | Aurinia Pharmaceuticals Inc. | 1,701,929 | $34.48M | 0.2% | $9.21 | 0.0% | COM | 05156V102 |
| ADPT | Adaptive Biotechnologies Corporation | 1,115,411 | $33.37M | 0.2% | $44.30 | -35.2% | COM | 00650F109 |
| — | Allakos Inc. | 339,690 | $32.39M | 0.2% | $78.63 | — | COM | 01671P100 |
| — | Assembly Biosciences, Inc. | 1,541,618 | $31.54M | 0.2% | $17.50 | — | COM | 045396108 |
| — | Kiniksa Pharmaceuticals, Ltd. | 2,799,577 | $30.96M | 0.2% | $17.35 | — | COM CL A | G5269C101 |
| — | ChemoCentryx, Inc. | 739,016 | $29.23M | 0.2% | $32.30 | — | COM | 16383L106 |
| — | Merus N.V. | 2,037,469 | $28.69M | 0.2% | $10.77 | — | COM | N5749R100 |
| URGN | UroGen Pharma Ltd. | 831,488 | $27.75M | 0.1% | $32.15 | -15.1% | COM | M96088105 |
| — | Aimmune Therapeutics, Inc. | 673,908 | $22.56M | 0.1% | $16.20 | — | COM | 00900T107 |
| — | Frequency Therapeutics, Inc. | 1,231,433 | $21.59M | 0.1% | $17.53 | — | COM | 35803L108 |
| ALKS | Alkermes plc | 793,130 | $16.18M | 0.1% | $27.81 | -28.5% | SHS | G01767105 |
| — | BioMarin Pharmaceutical Inc. | 15,000,000 | $15.84M | 0.1% | $1.01 | — | NOTE 0.599% 8/1/2024 | 09061GAH4 |
| UROV | Urovant Sciences Ltd. | 1,000,000 | $15.51M | 0.1% | $15.51 | — | SHS | G9381B108 |
| APLS | Apellis Pharmaceuticals, Inc. | 496,969 | $15.22M | 0.1% | $22.99 | +20.4% | COM | 03753U106 |
| XNCR | Xencor, Inc. | 428,120 | $14.72M | 0.1% | $11.07 | +230.1% | COM | 98401F105 |
| — | Aeglea BioTherapeutics, Inc. | 1,713,604 | $13.09M | 0.1% | $5.64 | — | COM | 00773J103 |
| — | HOOKIPA Pharma Inc. | 892,857 | $10.92M | 0.1% | $6.73 | — | COM | 43906K100 |
| CABA | Cabaletta Bio, Inc. | 636,363 | $8.89M | 0.0% | $11.85 | 0.0% | COM | 12674W109 |
| — | NextCure, Inc. | 150,000 | $8.45M | 0.0% | $14.98 | — | COM | 65343E108 |
| — | Idera Pharmaceuticals, Inc. | 4,608,786 | $8.388M | 0.0% | $1.32 | — | COM PAR | 45168K405 |
| — | Reata Pharmaceuticals, Inc. | 40,983 | $8.378M | 0.0% | $204.43 | — | CL A | 75615P103 |
| SGMO | Sangamo Therapeutics, Inc. | 999,823 | $8.369M | 0.0% | $11.28 | -18.5% | COM | 800677106 |
| PTGX | Protagonist Therapeutics, Inc. | 1,174,282 | $8.279M | 0.0% | $10.52 | -5.6% | COM | 74366E102 |
| MIRM | Mirum Pharmaceuticals, Inc. | 333,333 | $8.173M | 0.0% | $12.27 | -13.1% | COM | 604749101 |
| — | Abeona Therapeutics Inc. | 2,288,235 | $7.483M | 0.0% | $5.53 | — | COM | 00289Y107 |
| FLGT | Fulgent Genetics, Inc. | 569,444 | $7.346M | 0.0% | $11.30 | +5.2% | COM | 359664109 |
| IFRX | Inflarx N.V. | 1,778,415 | $7.043M | 0.0% | $2.91 | +0.5% | COM | N44821101 |
| — | Albireo Pharma, Inc. | 250,000 | $6.355M | 0.0% | $22.99 | — | COM | 01345P106 |
| — | Constellation Pharmaceuticals, Inc. | 133,333 | $6.281M | 0.0% | $6.73 | — | COM | 210373106 |
| — | Matinas BioPharma Holdings, Inc. | 2,632,348 | $5.975M | 0.0% | $1.03 | — | COM | 576810105 |
| — | Aravive, Inc. | 433,333 | $5.924M | 0.0% | $4.94 | — | COM | 03890D108 |
| — | Millendo Therapeutics, Inc. | 833,333 | $5.617M | 0.0% | $6.74 | — | COM | 60040X103 |
| — | Orchard Therapeutics plc | 405,702 | $5.578M | 0.0% | $14.53 | — | ADS | 68570P101 |
| CPRX | Catalyst Pharmaceuticals, Inc. | 1,341,902 | $5.032M | 0.0% | $2.70 | +73.1% | COM | 14888U101 |
| — | Syros Pharmaceuticals, Inc. | 690,167 | $4.769M | 0.0% | $13.72 | — | COM | 87184Q107 |
| — | Evofem Biosciences, Inc. | 756,813 | $4.67M | 0.0% | $6.02 | — | COM | 30048L104 |
| — | NGM Biopharmaceuticals, Inc. | 250,000 | $4.623M | 0.0% | $14.64 | — | COM | 62921N105 |
| — | Molecular Templates, Inc. | 316,730 | $4.429M | 0.0% | $7.45 | — | COM | 608550109 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 175,000 | $4.391M | 0.0% | $27.18 | -30.0% | COM | 22663K107 |
| — | Y-mAbs Therapeutics, Inc. | 138,514 | $4.329M | 0.0% | $27.77 | — | COM | 984241109 |
| — | Marker Therapeutics, Inc. | 1,500,000 | $4.32M | 0.0% | $5.55 | — | COM | 57055L107 |
| — | bluebird bio, Inc. | 40,000 | $3.51M | 0.0% | $41.25 | — | COM | 09609G100 |
| — | Bellicum Pharmaceuticals, Inc. | 2,677,818 | $3.454M | 0.0% | $22.31 | — | COM | 079481107 |
| VKTX | Viking Therapeutics, Inc. | 425,000 | $3.409M | 0.0% | $11.90 | -38.7% | COM | 92686J106 |
| — | G1 Therapeutics, Inc. | 127,236 | $3.363M | 0.0% | $37.05 | — | COM | 3621LQ109 |
| — | Menlo Therapeutics Inc. | 700,000 | $3.248M | 0.0% | $37.58 | — | COM | 586858102 |
| — | Harpoon Therapeutics, Inc. | 214,285 | $3.169M | 0.0% | $9.47 | — | COM | 41358P106 |
| GLPG | Galapagos NV | 13,072 | $2.704M | 0.0% | $51.50 | — | SPONSORED ADR | 36315X101 |
| AUTL | Autolus Therapeutics plc | 156,773 | $2.069M | 0.0% | $26.79 | — | SPONSORED ADS | 05280R100 |
| NTLA | Intellia Therapeutics, Inc. | 128,538 | $1.886M | 0.0% | $26.35 | -47.2% | COM | 45826J105 |
| ANAB | AnaptysBio, Inc. | 113,086 | $1.838M | 0.0% | $56.96 | -58.5% | COM | 032724106 |
| CTMX | CytomX Therapeutics, Inc. | 194,377 | $1.615M | 0.0% | $14.78 | -54.4% | COM | 23284F105 |
| IDYA | IDEAYA Biosciences, Inc. | 200,000 | $1.5M | 0.0% | $10.88 | -34.4% | COM | 45166A102 |
| — | Galmed Pharmaceuticals Ltd. | 215,594 | $1.246M | 0.0% | $11.90 | — | SHS | M47238106 |
| RCUS | Arcus Biosciences, Inc. | 121,534 | $1.227M | 0.0% | $15.69 | -46.4% | COM | 03969F109 |
| — | IVERIC bio, Inc. | 141,750 | $1.216M | 0.0% | $8.58 | — | COM | 46583P102 |
| — | Trillium Therapeutics Inc. | 1,100,000 | $1.133M | 0.0% | $6.16 | — | COM | 89620X506 |
| — | Leap Therapeutics, Inc. | 978,454 | $1.096M | 0.0% | $1.17 | — | COM | 52187K101 |
| — | Spring Bank Pharmaceuticals, Inc. | 613,144 | $969K | 0.0% | $10.97 | — | COM | 849431101 |
| — | Adamas Pharmaceuticals, Inc. | 172,630 | $654K | 0.0% | $14.46 | — | COM | 00548A106 |
| INFIQ | Infinity Pharmaceuticals, Inc. | 580,400 | $557K | 0.0% | $1.54 | -28.6% | COM | 45665G303 |
| — | Affimed N.V. | 200,000 | $548K | 0.0% | $6.30 | — | COM | N01045108 |
| — | Dynavax Technologies Corporation | 75,000 | $429K | 0.0% | $24.55 | — | COM | 268158201 |
| — | Sunesis Pharmaceuticals, Inc. | 556,665 | $188K | 0.0% | $4.37 | — | COM | 867328700 |